vs
IRIDEX CORP（IRIX）与迈心诺（MASI）财务数据对比。点击上方公司名可切换其他公司
迈心诺的季度营收约是IRIDEX CORP的25.2倍（$371.5M vs $14.7M），迈心诺同比增速更快（-26.4% vs -69.7%），过去两年IRIDEX CORP的营收复合增速更高（11.9% vs -17.7%）
IRIDEX Corporation是一家全球性医疗科技企业，主要研发、生产和销售面向眼科及医疗美容领域的激光类医疗设备，产品供应至北美、欧洲、亚太等地区的医疗机构与诊所，为眼部疾病治疗和医美项目提供微创解决方案。
迈心诺（Masimo Corporation）是总部位于美国加利福尼亚州尔湾的健康科技及消费电子企业，核心产品包括面向医院及家用场景的患者监护设备、无创传感器及配套软件平台，同时也布局了消费级音频和可穿戴设备赛道。
IRIX vs MASI — 直观对比
营收规模更大
MASI
是对方的25.2倍
$14.7M
营收增速更快
MASI
高出43.4%
-69.7%
两年增速更快
IRIX
近两年复合增速
-17.7%
损益表 — Q4 FY2025 vs Q3 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $14.7M | $371.5M |
| 净利润 | — | $-100.4M |
| 毛利率 | 37.2% | 62.1% |
| 营业利润率 | — | 22.5% |
| 净利率 | — | -27.0% |
| 营收同比 | -69.7% | -26.4% |
| 净利润同比 | — | -1124.5% |
| 每股收益（稀释后） | — | $-1.84 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收IRIXMASI
| Q4 25 | $14.7M | — | ||
| Q3 25 | $12.5M | $371.5M | ||
| Q2 25 | $13.6M | $370.9M | ||
| Q1 25 | $11.9M | $372.0M | ||
| Q4 24 | $12.7M | $600.7M | ||
| Q3 24 | $11.6M | $504.6M | ||
| Q2 24 | $12.6M | $496.3M | ||
| Q1 24 | $11.8M | $492.8M |
净利润IRIXMASI
| Q4 25 | — | — | ||
| Q3 25 | $-1.6M | $-100.4M | ||
| Q2 25 | $-994.0K | $51.3M | ||
| Q1 25 | $-1.7M | $-170.7M | ||
| Q4 24 | $-834.0K | $-349.6M | ||
| Q3 24 | $-1.9M | $9.8M | ||
| Q2 24 | $-2.7M | $16.0M | ||
| Q1 24 | $-3.5M | $18.9M |
毛利率IRIXMASI
| Q4 25 | 37.2% | — | ||
| Q3 25 | 32.1% | 62.1% | ||
| Q2 25 | 34.5% | 62.9% | ||
| Q1 25 | 42.5% | 62.9% | ||
| Q4 24 | 44.0% | 40.7% | ||
| Q3 24 | 37.3% | 52.2% | ||
| Q2 24 | 40.7% | 51.3% | ||
| Q1 24 | 37.9% | 49.0% |
营业利润率IRIXMASI
| Q4 25 | — | — | ||
| Q3 25 | -11.3% | 22.5% | ||
| Q2 25 | -6.9% | 17.4% | ||
| Q1 25 | -1.7% | 21.0% | ||
| Q4 24 | -3.9% | -59.8% | ||
| Q3 24 | -16.1% | 6.0% | ||
| Q2 24 | -20.9% | 5.7% | ||
| Q1 24 | -28.0% | 6.9% |
净利率IRIXMASI
| Q4 25 | — | — | ||
| Q3 25 | -12.6% | -27.0% | ||
| Q2 25 | -7.3% | 13.8% | ||
| Q1 25 | -14.2% | -45.9% | ||
| Q4 24 | -6.6% | -58.2% | ||
| Q3 24 | -16.7% | 1.9% | ||
| Q2 24 | -21.2% | 3.2% | ||
| Q1 24 | -29.5% | 3.8% |
每股收益（稀释后）IRIXMASI
| Q4 25 | — | — | ||
| Q3 25 | $-0.09 | $-1.84 | ||
| Q2 25 | $-0.06 | $0.94 | ||
| Q1 25 | $-0.10 | $-3.12 | ||
| Q4 24 | $-0.05 | $-6.54 | ||
| Q3 24 | $-0.12 | $0.18 | ||
| Q2 24 | $-0.16 | $0.29 | ||
| Q1 24 | $-0.21 | $0.35 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $6.0M | $312.3M |
| 总债务越低越好 | — | $559.1M |
| 股东权益账面价值 | — | $810.0M |
| 总资产 | $29.2M | $1.8B |
| 负债/权益比越低杠杆越低 | — | 0.69× |
8季度趋势，按日历期对齐
现金及短期投资IRIXMASI
| Q4 25 | $6.0M | — | ||
| Q3 25 | $5.6M | $312.3M | ||
| Q2 25 | $6.8M | $149.6M | ||
| Q1 25 | $7.2M | $130.8M | ||
| Q4 24 | $2.4M | $177.6M | ||
| Q3 24 | $3.9M | $158.5M | ||
| Q2 24 | $4.1M | $129.6M | ||
| Q1 24 | $5.4M | $157.6M |
总债务IRIXMASI
| Q4 25 | — | — | ||
| Q3 25 | — | $559.1M | ||
| Q2 25 | — | $613.7M | ||
| Q1 25 | — | $651.0M | ||
| Q4 24 | $1.0M | $765.2M | ||
| Q3 24 | $1.4M | $772.6M | ||
| Q2 24 | — | $781.6M | ||
| Q1 24 | — | $876.0M |
股东权益IRIXMASI
| Q4 25 | — | — | ||
| Q3 25 | $4.7M | $810.0M | ||
| Q2 25 | $6.1M | $1.0B | ||
| Q1 25 | $852.0K | $946.4M | ||
| Q4 24 | $2.1M | $1.1B | ||
| Q3 24 | $2.6M | $1.5B | ||
| Q2 24 | $4.2M | $1.4B | ||
| Q1 24 | $6.5M | $1.4B |
总资产IRIXMASI
| Q4 25 | $29.2M | — | ||
| Q3 25 | $28.4M | $1.8B | ||
| Q2 25 | $31.6M | $2.4B | ||
| Q1 25 | $34.2M | $2.3B | ||
| Q4 24 | $29.1M | $2.6B | ||
| Q3 24 | $30.2M | $3.1B | ||
| Q2 24 | $31.2M | $2.9B | ||
| Q1 24 | $34.1M | $3.0B |
负债/权益比IRIXMASI
| Q4 25 | — | — | ||
| Q3 25 | — | 0.69× | ||
| Q2 25 | — | 0.59× | ||
| Q1 25 | — | 0.69× | ||
| Q4 24 | 0.48× | 0.73× | ||
| Q3 24 | 0.53× | 0.53× | ||
| Q2 24 | — | 0.57× | ||
| Q1 24 | — | 0.64× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $56.8M |
| 自由现金流经营现金流 - 资本支出 | — | $50.9M |
| 自由现金流率自由现金流/营收 | — | 13.7% |
| 资本支出强度资本支出/营收 | — | 1.6% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $191.0M |
8季度趋势，按日历期对齐
经营现金流IRIXMASI
| Q4 25 | — | — | ||
| Q3 25 | $-1.2M | $56.8M | ||
| Q2 25 | $-397.0K | $69.4M | ||
| Q1 25 | $-1.1M | $31.1M | ||
| Q4 24 | $-1.2M | $50.5M | ||
| Q3 24 | $-3.1M | $25.6M | ||
| Q2 24 | $-1.3M | $74.5M | ||
| Q1 24 | $-1.6M | $45.8M |
自由现金流IRIXMASI
| Q4 25 | — | — | ||
| Q3 25 | $-1.2M | $50.9M | ||
| Q2 25 | $-410.0K | $65.6M | ||
| Q1 25 | $-1.2M | $28.5M | ||
| Q4 24 | $-1.2M | $46.0M | ||
| Q3 24 | $-3.1M | $16.9M | ||
| Q2 24 | — | $66.9M | ||
| Q1 24 | $-1.7M | $37.6M |
自由现金流率IRIXMASI
| Q4 25 | — | — | ||
| Q3 25 | -9.4% | 13.7% | ||
| Q2 25 | -3.0% | 17.7% | ||
| Q1 25 | -9.8% | 7.7% | ||
| Q4 24 | -9.8% | 7.7% | ||
| Q3 24 | -26.5% | 3.3% | ||
| Q2 24 | — | 13.5% | ||
| Q1 24 | -14.0% | 7.6% |
资本支出强度IRIXMASI
| Q4 25 | — | — | ||
| Q3 25 | 0.1% | 1.6% | ||
| Q2 25 | 0.1% | 1.0% | ||
| Q1 25 | 0.1% | 0.7% | ||
| Q4 24 | 0.1% | 0.7% | ||
| Q3 24 | 0.0% | 1.7% | ||
| Q2 24 | 0.0% | 1.5% | ||
| Q1 24 | 0.0% | 1.7% |
现金转化率IRIXMASI
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 1.35× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 2.61× | ||
| Q2 24 | — | 4.66× | ||
| Q1 24 | — | 2.42× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
